D. J. Theo Wagener

Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival

Thierry Conroy, Pierre Étienne, Antoine Adenis et al. · Annals of Oncology · 2002 · 75 citations · Full text

Oncology, Esophageal Cancer, Gastrointestinal Oncology +6

Phase I and pharmacokinetic study of the orally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors

Cornelis J. A. Punt, L. van Maanen, C.J. Bol et al. · Anti-Cancer Drugs · 2001 · 72 citations

Weekly Infusional High-Dose Fluorouracil (HD-FU), HD-FU Plus Folinic Acid (HD-FU/FA), or HD-FU/FA Plus Biweekly Cisplatin in Advanced Gastric Cancer: Randomized Phase II Trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie

Manfred P. Lutz, H. Wilke, D. J. Theo Wagener et al. · Journal of Clinical Oncology · 2007 · 71 citations

Jejunal lymphoma in a patient with primary adult-onset hypogammaglobulinemia and nodular lymphoid hyperplasia of the small intestine

C. B. H. W. Lamers, D. J. Theo Wagener, Karel J.M. Assmann et al. · Digestive Diseases and Sciences · 1980 · 40 citations

Lymphoid Neoplasia, Primary Adult-onset Hypogammaglobulinemia, Small Intestine +4

Lipophilic analogs of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship study

Leon A. G. M. van den Broek, Ester Lázaro, Zbigniew Żylicz et al. · Journal of Medicinal Chemistry · 1989 · 34 citations